113 related articles for article (PubMed ID: 28783774)
1. Progressive hair loss.
Power DV; Disse M; Hordinsky M
J Fam Pract; 2017 Aug; 66(8):521-523. PubMed ID: 28783774
[TBL] [Abstract][Full Text] [Related]
2. Intralesional Triamcinolone Acetonide Versus Topical Betamethasone Valearate in the Management of Localized Alopecia Areata.
Devi M; Rashid A; Ghafoor R
J Coll Physicians Surg Pak; 2015 Dec; 25(12):860-2. PubMed ID: 26691357
[TBL] [Abstract][Full Text] [Related]
3. Treatment of severe alopecia areata with intralesional steroid injections.
Chang KH; Rojhirunsakool S; Goldberg LJ
J Drugs Dermatol; 2009 Oct; 8(10):909-12. PubMed ID: 19852119
[TBL] [Abstract][Full Text] [Related]
4. Alopecia in women.
Thiedke CC
Am Fam Physician; 2003 Mar; 67(5):1007-14. PubMed ID: 12643360
[TBL] [Abstract][Full Text] [Related]
5. Topical tretinoin as an adjunctive therapy with intralesional triamcinolone acetonide for alopecia areata. Clinical experience in northern Saudi Arabia.
Kubeyinje EP; C'Mathur M
Int J Dermatol; 1997 Apr; 36(4):320. PubMed ID: 9169343
[No Abstract] [Full Text] [Related]
6. Topical and intralesional therapies for alopecia areata.
Alkhalifah A
Dermatol Ther; 2011; 24(3):355-63. PubMed ID: 21689245
[TBL] [Abstract][Full Text] [Related]
7. Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study.
Chu TW; AlJasser M; Alharbi A; Abahussein O; McElwee K; Shapiro J
J Am Acad Dermatol; 2015 Aug; 73(2):338-40. PubMed ID: 26183987
[No Abstract] [Full Text] [Related]
8. Eyebrow regrowth in patients with frontal fibrosing alopecia treated with intralesional triamcinolone acetonide.
Donovan JC; Samrao A; Ruben BS; Price VH
Br J Dermatol; 2010 Nov; 163(5):1142-4. PubMed ID: 20716217
[No Abstract] [Full Text] [Related]
9. Erosive pustular dermatosis of the scalp following topical latanoprost for androgenetic alopecia.
Vaccaro M; Barbuzza O; Borgia F; Cannavò SP
Dermatol Ther; 2015; 28(2):65-7. PubMed ID: 25627907
[No Abstract] [Full Text] [Related]
10. How effective is intralesional injection of triamcinolone acetonide compared with topical treatments in inducing and maintaining hair growth in patients with alopecia areata? A Critically Appraised Topic.
Kassim JM; Shipman AR; Szczecinska W; Siah TW; Lam M; Chalmers J; Macbeth AE
Br J Dermatol; 2014 Apr; 170(4):766-71. PubMed ID: 24484438
[No Abstract] [Full Text] [Related]
11. Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata.
Ganjoo S; Thappa DM
Indian J Dermatol Venereol Leprol; 2013; 79(3):408-17. PubMed ID: 23619446
[TBL] [Abstract][Full Text] [Related]
12. Systemic corticosteroids in alopecia totalis.
Unger WP
Can Med Assoc J; 1973 Jan; 108(2):177-80. PubMed ID: 4684625
[TBL] [Abstract][Full Text] [Related]
13. TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold.
Craddock LN; Cooley DM; Endo JO; Longley BJ; Caldera F
Dermatol Online J; 2017 Mar; 23(3):. PubMed ID: 28329519
[TBL] [Abstract][Full Text] [Related]
14. Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs.
Kubeyinje EP
East Afr Med J; 1994 Oct; 71(10):674-5. PubMed ID: 7821250
[TBL] [Abstract][Full Text] [Related]
15. Periocular steroids in conjunctival reactive lymphoid hyperplasia, a new approach?
Ahmed TY; Agarwal PK; Roberts F; Diaper CJ
Clin Exp Ophthalmol; 2011 Aug; 39(6):576-7. PubMed ID: 21631657
[No Abstract] [Full Text] [Related]
16. A hairy paradox: congenital triangular alopecia with a central hair tuft.
Assouly P; Happle R
Dermatology; 2010; 221(2):107-9. PubMed ID: 20587991
[TBL] [Abstract][Full Text] [Related]
17. Dermal Titanium Dioxide Deposition Associated With Intralesional Triamcinolone Injection.
Cohen BE; Bashey S; Cole C; Abraham JL; Ragsdale B; Ngo B
Am J Dermatopathol; 2016 Dec; 38(12):e163-e166. PubMed ID: 27861183
[TBL] [Abstract][Full Text] [Related]
18. Temporomandibular joint osteo-arthrosis-histopathological study of the effects of intra-articular injection of triamcinolone acetonide.
Dargan SK
Saudi Med J; 2001 Feb; 22(2):180. PubMed ID: 11299420
[No Abstract] [Full Text] [Related]
19. Mitogen-Activated Protein Kinase Inhibitor-Induced Inflammatory Alopecia in Woman With Ovarian Cancer.
Rose L; Minta A; Plaza J; Cohn DE; Dulmage B
J Drugs Dermatol; 2024 Apr; 23(4):e102-e103. PubMed ID: 38564383
[TBL] [Abstract][Full Text] [Related]
20. Intralesional steroid for orbital manifestations of Rosai-Dorfman disease.
Petrushkin H; Salisbury J; O'Sullivan E
Clin Exp Ophthalmol; 2015 Jul; 43(5):483-5. PubMed ID: 25488543
[No Abstract] [Full Text] [Related]
[Next] [New Search]
